Multiple Sclerosis
Conference Coverage
MRI biomarker to be tested in MS
A new prospective trial aims to prove that central vein sign can distinguish MS from clinical mimics.
Opinion
New guidelines on MRI use in patients with MS explained
Family physicians are often the ones who make the initial diagnosis of MS.
Conference Coverage
Ozanimod shows long-term safety, despite a pandemic
Open-label study confirms efficacy and COVID-19–related safety.
Conference Coverage
B-cell therapy for MS may impact COVID-19 vaccination
A prospective study found improved neutralizing antibody response with more time elapsed since therapy and vaccination.
Livin' on the MDedge
Tastier chocolate may be healthier chocolate
Plus: A villain in milk, low-tech radiation detection, and in-head localization.
Conference Coverage
Evidence mounts for paramagnetic rim lesions in diagnosing MS
The presence and number of iron rim lesions hold a prognostic value for long-term disability in MS.
Conference Coverage
Spinal cord atrophy predicts ‘silent progression’ in MS
This is a potentially important biomarker for disease progression that may otherwise go unrecognized by clinicians and patients.
From the Journals
Sepsis common cause of ICU admissions in patients with MS
Feature
Rituximab and COVID-19 vaccines: Studies begin to answer key questions
This article aims to summarize the latest research on how rituximab affects humoral and cell-mediated response following a COVID-19 vaccine...
Latest News
Epstein-Barr virus a likely leading cause of multiple sclerosis
This study is the first to provide compelling evidence of a causal link between EBV and MS.